Laboratory Medicine ›› 2016, Vol. 31 ›› Issue (1): 76-77.DOI: 10.3969/j.issn.1673-8640.2016.01.017
• Orginal Article • Previous Articles Next Articles
Online:2016-01-31
Published:2016-02-16
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2016.01.017
| 母体IgG-抗A（B）效价 | 母婴ABO血型不合 | HDN发病率[例（%）] | ||
|---|---|---|---|---|
| IgG抗-A（例） | IgG抗-B（例） | 合计（例） | ||
| ≤1∶32 | 278 | 251 | 529 | 64（12.1） |
| 1∶64 | 253 | 228 | 481 | 76（15.8）* |
| 1∶128 | 273 | 237 | 510 | 259（50.8）*＃ |
| 1∶256 | 137 | 114 | 251 | 184（73.3）*＃△ |
| ≥1∶512 | 52 | 51 | 103 | 86（83.5）*＃△ |
| 母体IgG-抗A（B）效价 | 母婴ABO血型不合 | HDN发病率[例（%）] | ||
|---|---|---|---|---|
| IgG抗-A（例） | IgG抗-B（例） | 合计（例） | ||
| ≤1∶32 | 278 | 251 | 529 | 64（12.1） |
| 1∶64 | 253 | 228 | 481 | 76（15.8）* |
| 1∶128 | 273 | 237 | 510 | 259（50.8）*＃ |
| 1∶256 | 137 | 114 | 251 | 184（73.3）*＃△ |
| ≥1∶512 | 52 | 51 | 103 | 86（83.5）*＃△ |
| 1 | 温洁新,马西霞,孙稔侠. O型血孕妇血清中IgG抗(A)B抗体效价与ABO新生儿溶血病的相关分析[J].广东医学,2010,31(11):1430-1431. |
| 2 | 李莉.母婴血型不合导致的新生儿溶血病实验室检测分析[J].吉林医学,2014,35(4):771-772. |
| 3 | 张丹,申晓环,张静蕊. 孕妇IgG抗A或抗B效价与ABO 系统新生儿溶血病的关系[J].临床军医杂志,2013,41(11):1182-1184. |
| 4 | 胡亚美,江载芳,诸福棠. 实用儿科学[M]. 第7版. 北京: 人民卫生出版社,2002:477. |
| 5 | 桂芹,王昱,陈晶,等.孕母血型抗体与新生儿ABO溶血病的关系研究[J].第三军医大学学报,2007,29(7):632-634. |
| 6 | 曾蔚越,谭世桥,甘萍,等.母儿血型不合与新生儿溶血病[J].实用妇产科杂志,1993,9(3):148-151. |
| [1] | FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114. |
| [2] | SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120. |
| [3] | LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129. |
| [4] | YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140. |
| [5] | XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146. |
| [6] | CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152. |
| [7] | . [J]. Laboratory Medicine, 2023, 38(12): 1153-1156. |
| [8] | . [J]. Laboratory Medicine, 2023, 38(12): 1157-1159. |
| [9] | WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166. |
| [10] | YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172. |
| [11] | DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176. |
| [12] | GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182. |
| [13] | . [J]. Laboratory Medicine, 2023, 38(12): 1183-1185. |
| [14] | . [J]. Laboratory Medicine, 2023, 38(12): 1186-1190. |
| [15] | . [J]. Laboratory Medicine, 2023, 38(12): 1191-1194. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
